Schedule 13D ownership disclosure

ITEOS THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 46565G104

Event date: 2025-07-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

    Shares: 3,826,692.00 · Class: 9.99%

  • KEVIN TANGReported CIK 0001178579

    Shares: 3,826,692.00 · Class: 9.99%

  • TANG CAPITAL PARTNERS, LPReported CIK 0001191935

    Shares: 2,618,219.00 · Class: 6.84%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LPReported CIK 0002064011

    Shares: 1,208,473.00 · Class: 3.15%

  • TANG CAPITAL PARTNERS III, INCReported CIK 0002036763

    Shares: 0.00 · Class: 0%

  • TANG CAPITAL PARTNERS IV, INCReported CIK 0002036770

    Shares: 0.00 · Class: 0%

  • CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-010765
Form type
SCHEDULE 13D/A
Filer
TANG CAPITAL MANAGEMENT LLC
CIK
CIK 1232621
Filed
Jul 22, 2025
Reporting period
Jul 18, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub